vs
AMPCO PITTSBURGH CORP（AP）与VERACYTE, INC.（VCYT）财务数据对比。点击上方公司名可切换其他公司
VERACYTE, INC.的季度营收约是AMPCO PITTSBURGH CORP的1.3倍（$139.1M vs $104.4M），VERACYTE, INC.净利率更高（20.6% vs -55.2%，领先75.9%），VERACYTE, INC.同比增速更快（21.5% vs 11.5%），过去两年VERACYTE, INC.的营收复合增速更高（10.2% vs -2.6%）
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
Veracyte是一家领先的分子诊断企业，专注开发专有的基因组检测方案，可实现癌症及其他复杂疾病的早期精准检测，产品服务于医疗机构以优化临床决策，核心市场位于美国，正稳步拓展全球业务布局。
AP vs VCYT — 直观对比
营收规模更大
VCYT
是对方的1.3倍
$104.4M
营收增速更快
VCYT
高出10.0%
11.5%
净利率更高
VCYT
高出75.9%
-55.2%
两年增速更快
VCYT
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $104.4M | $139.1M |
| 净利润 | $-57.7M | $28.7M |
| 毛利率 | — | 72.7% |
| 营业利润率 | -54.0% | 16.3% |
| 净利率 | -55.2% | 20.6% |
| 营收同比 | 11.5% | 21.5% |
| 净利润同比 | -1958.9% | — |
| 每股收益（稀释后） | $-2.87 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APVCYT
| Q1 26 | — | $139.1M | ||
| Q4 25 | $104.4M | $140.6M | ||
| Q3 25 | $103.7M | $131.9M | ||
| Q2 25 | $108.9M | $130.2M | ||
| Q1 25 | $99.2M | $114.5M | ||
| Q4 24 | $93.6M | $118.6M | ||
| Q3 24 | $92.1M | $115.9M | ||
| Q2 24 | $107.1M | $114.4M |
净利润APVCYT
| Q1 26 | — | $28.7M | ||
| Q4 25 | $-57.7M | $41.1M | ||
| Q3 25 | $-2.2M | $19.1M | ||
| Q2 25 | $-7.3M | $-980.0K | ||
| Q1 25 | $1.1M | $7.0M | ||
| Q4 24 | $3.1M | $5.1M | ||
| Q3 24 | $-2.0M | $15.2M | ||
| Q2 24 | $2.0M | $5.7M |
毛利率APVCYT
| Q1 26 | — | 72.7% | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 69.2% | ||
| Q2 25 | — | 69.0% | ||
| Q1 25 | — | 69.5% | ||
| Q4 24 | — | 66.4% | ||
| Q3 24 | — | 68.2% | ||
| Q2 24 | — | 68.1% |
营业利润率APVCYT
| Q1 26 | — | 16.3% | ||
| Q4 25 | -54.0% | 26.4% | ||
| Q3 25 | 1.1% | 17.4% | ||
| Q2 25 | -2.8% | -4.0% | ||
| Q1 25 | 3.9% | 2.5% | ||
| Q4 24 | 5.5% | 3.5% | ||
| Q3 24 | 2.0% | 10.4% | ||
| Q2 24 | 4.7% | 4.0% |
净利率APVCYT
| Q1 26 | — | 20.6% | ||
| Q4 25 | -55.2% | 29.3% | ||
| Q3 25 | -2.1% | 14.5% | ||
| Q2 25 | -6.7% | -0.8% | ||
| Q1 25 | 1.2% | 6.2% | ||
| Q4 24 | 3.3% | 4.3% | ||
| Q3 24 | -2.1% | 13.1% | ||
| Q2 24 | 1.9% | 5.0% |
每股收益（稀释后）APVCYT
| Q1 26 | — | $0.35 | ||
| Q4 25 | $-2.87 | $0.50 | ||
| Q3 25 | $-0.11 | $0.24 | ||
| Q2 25 | $-0.36 | $-0.01 | ||
| Q1 25 | $0.06 | $0.09 | ||
| Q4 24 | $0.16 | $0.07 | ||
| Q3 24 | $-0.10 | $0.19 | ||
| Q2 24 | $0.10 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $439.1M |
| 总债务越低越好 | $117.9M | — |
| 股东权益账面价值 | $32.6M | $1.3B |
| 总资产 | $495.4M | $1.4B |
| 负债/权益比越低杠杆越低 | 3.61× | — |
8季度趋势，按日历期对齐
现金及短期投资APVCYT
| Q1 26 | — | $439.1M | ||
| Q4 25 | $10.7M | $362.6M | ||
| Q3 25 | $15.0M | $315.6M | ||
| Q2 25 | $9.9M | $219.5M | ||
| Q1 25 | $7.1M | $186.1M | ||
| Q4 24 | $15.4M | $239.1M | ||
| Q3 24 | $11.8M | $274.1M | ||
| Q2 24 | $7.9M | $235.9M |
总债务APVCYT
| Q1 26 | — | — | ||
| Q4 25 | $117.9M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $115.9M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $119.4M | — |
股东权益APVCYT
| Q1 26 | — | $1.3B | ||
| Q4 25 | $32.6M | $1.3B | ||
| Q3 25 | $60.1M | $1.3B | ||
| Q2 25 | $62.7M | $1.2B | ||
| Q1 25 | $64.6M | $1.2B | ||
| Q4 24 | $58.9M | $1.2B | ||
| Q3 24 | $61.3M | $1.2B | ||
| Q2 24 | $58.0M | $1.1B |
总资产APVCYT
| Q1 26 | — | $1.4B | ||
| Q4 25 | $495.4M | $1.4B | ||
| Q3 25 | $524.4M | $1.4B | ||
| Q2 25 | $537.2M | $1.3B | ||
| Q1 25 | $536.2M | $1.3B | ||
| Q4 24 | $530.9M | $1.3B | ||
| Q3 24 | $547.4M | $1.3B | ||
| Q2 24 | $560.8M | $1.2B |
负债/权益比APVCYT
| Q1 26 | — | — | ||
| Q4 25 | 3.61× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.98× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 2.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $35.2M |
| 自由现金流经营现金流 - 资本支出 | $-64.0K | — |
| 自由现金流率自由现金流/营收 | -0.1% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | 1.23× |
| 过去12个月自由现金流最近4个季度 | $-8.1M | — |
8季度趋势，按日历期对齐
经营现金流APVCYT
| Q1 26 | — | $35.2M | ||
| Q4 25 | $2.7M | $52.6M | ||
| Q3 25 | $6.3M | $44.8M | ||
| Q2 25 | $-2.3M | $33.6M | ||
| Q1 25 | $-5.3M | $5.4M | ||
| Q4 24 | $7.5M | $24.5M | ||
| Q3 24 | $11.4M | $30.0M | ||
| Q2 24 | $-5.3M | $29.6M |
自由现金流APVCYT
| Q1 26 | — | — | ||
| Q4 25 | $-64.0K | $48.8M | ||
| Q3 25 | $3.3M | $42.0M | ||
| Q2 25 | $-3.8M | $32.3M | ||
| Q1 25 | $-7.5M | $3.5M | ||
| Q4 24 | $3.7M | $20.4M | ||
| Q3 24 | $8.4M | $27.7M | ||
| Q2 24 | $-8.0M | $26.8M |
自由现金流率APVCYT
| Q1 26 | — | — | ||
| Q4 25 | -0.1% | 34.7% | ||
| Q3 25 | 3.2% | 31.8% | ||
| Q2 25 | -3.5% | 24.8% | ||
| Q1 25 | -7.5% | 3.1% | ||
| Q4 24 | 4.0% | 17.2% | ||
| Q3 24 | 9.1% | 23.9% | ||
| Q2 24 | -7.5% | 23.4% |
资本支出强度APVCYT
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 2.7% | ||
| Q3 25 | 2.9% | 2.1% | ||
| Q2 25 | 1.3% | 1.0% | ||
| Q1 25 | 2.2% | 1.6% | ||
| Q4 24 | 4.0% | 3.5% | ||
| Q3 24 | 3.2% | 1.9% | ||
| Q2 24 | 2.5% | 2.4% |
现金转化率APVCYT
| Q1 26 | — | 1.23× | ||
| Q4 25 | — | 1.28× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | 0.76× | ||
| Q4 24 | 2.40× | 4.80× | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | -2.64× | 5.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
VCYT
| Testing revenue | $135.1M | 97% |
| Product revenue | $3.7M | 3% |
| Biopharmaceutical and other revenue | $301.0K | 0% |
